|
Sunday, September 20, 2015 7:17 AM
|
Venöse Multiple Sklerose, CVI & SVI, CCSVI shared CCSVI at UBC MS Clinic - Information and Support's post.
FYI, 10 year randomized control trial of interferon ß-1b shows no benefit to persons with secondary progressive MS. Importantly, follow up MRI proved to be useless in explaining differences between subjects in disease progression. A 10-year follow-up of the European multicenter trial of interferon ß-1b in secondary-progressive multiple sclerosis. - PubMed - NCBI  FYI, 10 year randomized control trial of interferon ß-1b shows no benefit to persons with secondary progressive MS. Importantly, follow up MRI proved to be useless in explaining differences between subjects in disease progression. A 10-year follow-up of the European multicenter trial of interferon ß-1b in secondary-progressive multiple sclerosis. - PubMed - NCBI http://www.ncbi.nlm.nih.gov/m/pubmed/26362898/
|